MX2023000105A - Metodos para diagnosticar patogenos respiratorios y predecir los resultados relacionados con el covid-19. - Google Patents

Metodos para diagnosticar patogenos respiratorios y predecir los resultados relacionados con el covid-19.

Info

Publication number
MX2023000105A
MX2023000105A MX2023000105A MX2023000105A MX2023000105A MX 2023000105 A MX2023000105 A MX 2023000105A MX 2023000105 A MX2023000105 A MX 2023000105A MX 2023000105 A MX2023000105 A MX 2023000105A MX 2023000105 A MX2023000105 A MX 2023000105A
Authority
MX
Mexico
Prior art keywords
covid
predicting
methods
respiratory pathogens
related outcomes
Prior art date
Application number
MX2023000105A
Other languages
English (en)
Spanish (es)
Inventor
Kathleen Barnes
Ivana Yang
Christopher Gignoux
Rasika Mathias
Paul Norman
Alem Taye
Rishi Porecha
Bret Barnes
Brett Peterson
Original Assignee
Univ Colorado Regents
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Colorado Regents filed Critical Univ Colorado Regents
Publication of MX2023000105A publication Critical patent/MX2023000105A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6858—Allele-specific amplification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/154—Methylation markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
MX2023000105A 2020-06-23 2021-06-23 Metodos para diagnosticar patogenos respiratorios y predecir los resultados relacionados con el covid-19. MX2023000105A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063042669P 2020-06-23 2020-06-23
PCT/US2021/038763 WO2021262894A1 (en) 2020-06-23 2021-06-23 Methods for diagnosing respiratory pathogens and predicting covid-19 related outcomes

Publications (1)

Publication Number Publication Date
MX2023000105A true MX2023000105A (es) 2023-04-25

Family

ID=79281779

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2023000105A MX2023000105A (es) 2020-06-23 2021-06-23 Metodos para diagnosticar patogenos respiratorios y predecir los resultados relacionados con el covid-19.

Country Status (10)

Country Link
US (1) US20240093318A1 (cg-RX-API-DMAC7.html)
EP (1) EP4168593A4 (cg-RX-API-DMAC7.html)
JP (1) JP2023532444A (cg-RX-API-DMAC7.html)
KR (1) KR20230038486A (cg-RX-API-DMAC7.html)
CN (1) CN116096920A (cg-RX-API-DMAC7.html)
AU (1) AU2021297245A1 (cg-RX-API-DMAC7.html)
BR (1) BR112022026509A2 (cg-RX-API-DMAC7.html)
CA (1) CA3184128A1 (cg-RX-API-DMAC7.html)
MX (1) MX2023000105A (cg-RX-API-DMAC7.html)
WO (1) WO2021262894A1 (cg-RX-API-DMAC7.html)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20230158101A (ko) * 2021-03-18 2023-11-17 더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 수술 위험도 점수를 생성하는 시스템 및 방법 및 그 용도
EP4303326A1 (fr) * 2022-07-06 2024-01-10 Biomérieux Determination du risque de deces d'un sujet infecte par un virus respiratoire par mesure du niveau d'expression du gene oas2
WO2024008955A1 (en) * 2022-07-08 2024-01-11 Age Labs As Method of screening for severe covid-19 susceptibility
CN117587124A (zh) * 2022-08-16 2024-02-23 武汉艾米森生命科技有限公司 诊断胰腺癌的检测试剂和试剂盒及应用
EP4484575A1 (de) * 2023-06-30 2025-01-01 Cerascreen GmbH Markersequenzen zur diagnose und therapiesteuerung von patienten mit testosteron-defizienz

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4751180A (en) 1985-03-28 1988-06-14 Chiron Corporation Expression using fused genes providing for protein product
US4935233A (en) 1985-12-02 1990-06-19 G. D. Searle And Company Covalently linked polypeptide cell modulators
US8114414B2 (en) 1994-11-08 2012-02-14 The Trustees Of The University Of Pennsylvania Compositions and methods for treatment of cervical cancer
EP2298900A1 (en) 1996-09-17 2011-03-23 Novartis Vaccines and Diagnostics, Inc. Compositions and methods for treating intracellular diseases
US6099848A (en) 1997-11-18 2000-08-08 The Trustees Of The University Of Pennsylvania Immunogenic compositions comprising DAL/DAT double-mutant, auxotrophic, attenuated strains of Listeria and their methods of use
GB9726555D0 (en) 1997-12-16 1998-02-11 Smithkline Beecham Plc Vaccine
WO2001041782A2 (en) 1999-12-09 2001-06-14 Chiron Corporation Method for administering a cytokine to the central nervous system and the lymphatic system
US6855320B2 (en) 2000-03-29 2005-02-15 The Trustees Of The University Of Pennsylvania Fusion of non-hemolytic, truncated form of listeriolysin O to antigens to enhance immunogenicity
JP2004500405A (ja) 2000-03-29 2004-01-08 ザ トラスティーズ オブ ザ ユニバーシティー オブ ペンシルヴァニア 抗原の免疫原性を増強するための組成物および方法
AU2001276371A1 (en) * 2000-06-30 2002-01-14 Epigenomics Ag Method and nucleic acids for analysing the methylation of genes implicated pharmacogenomics
US8771702B2 (en) 2001-03-26 2014-07-08 The Trustees Of The University Of Pennsylvania Non-hemolytic LLO fusion proteins and methods of utilizing same
WO2003102168A1 (en) 2002-05-29 2003-12-11 The Regents Of The University Of California Attenuated listeria spp. and methods for using the same
AU2004204751A1 (en) 2003-01-09 2004-07-29 The Trustees Of The University Of Pennsylvania Compositions, methods and kits for enhancing the immunogenicity of a bacterial vaccine vector
ATE552843T1 (de) 2003-02-06 2012-04-15 Aduro Biotech Listerien deren eindringen in nicht-phagozytische zellen abgeschwächt ist, impfstoffe, die diese listerien enthalten und deren verwendungen
US7935804B2 (en) 2006-03-01 2011-05-03 Aduro Biotech Engineered Listeria and methods of use thereof
US7665238B2 (en) 2006-04-03 2010-02-23 S.C. Johnson & Son, Inc. Air freshener with holder
DK2148923T3 (da) 2007-05-18 2012-12-03 Medimmune Llc Konservering af biologisk aktive materialer med frysetørret skum
JP5985397B2 (ja) 2009-11-11 2016-09-06 アドバクシス インコーポレイテッド 組換えリステリア株およびそれを含む免疫原性組成物
WO2011082436A1 (en) * 2010-01-04 2011-07-07 Lineagen, Inc. Dna methylation biomarkers of lung function
ES2728782T3 (es) 2012-05-25 2019-10-28 Univ California Métodos y composiciones para la modificación de ADN objetivo dirigida por ARN y para la modulación de la transcripción dirigida por ARN
AU2013370210B2 (en) 2012-12-27 2018-06-14 Aduro Biotech, Inc. Signal peptide fusion partners facilitating listerial expression of antigenic sequences and methods of preparation and use thereof
CN106794235A (zh) 2014-07-18 2017-05-31 阿德瓦希斯公司 用于引起抗肿瘤应答的基于李斯特菌的免疫原性组合物
WO2016011357A1 (en) 2014-07-18 2016-01-21 Advaxis, Inc. Combination of a pd-1 antagonist and a listeria-based vaccine for treating prostate cancer
MA41217A (fr) 2014-12-19 2017-10-24 Advaxis Inc Polythérapies ayant des souches de listeria recombinées
BR112019018272A2 (pt) * 2017-03-02 2020-07-28 Youhealth Oncotech, Limited marcadores metilação para diagnosticar hepatocelular carcinoma e câncer
CA3055895A1 (en) * 2017-03-10 2018-09-13 Self-Screen B.V. A methylation classifier for detection of hpv-induced invasive cancers, nonhpv- induced gynaecological and anogenital cancers and their high-grade precursor lesions

Also Published As

Publication number Publication date
EP4168593A4 (en) 2024-11-27
JP2023532444A (ja) 2023-07-28
KR20230038486A (ko) 2023-03-20
CN116096920A (zh) 2023-05-09
CA3184128A1 (en) 2021-12-30
AU2021297245A1 (en) 2023-02-02
WO2021262894A1 (en) 2021-12-30
US20240093318A1 (en) 2024-03-21
EP4168593A1 (en) 2023-04-26
BR112022026509A2 (pt) 2023-03-07

Similar Documents

Publication Publication Date Title
Cafarchia et al. Molecular epidemiology, phylogeny and evolution of dermatophytes
BR112022026509A2 (pt) Métodos para diagnosticar patógenos respiratórios e prever resultados relacionados à covid-19
CY1124376T1 (el) Συνδυαστικη αναλυση μεγεθους και καταμετρησης στο μητρικο πλασμα για την ανιχνευση εμβρυϊκων υποχρωμοσωμικων ανωμαλιων
MY181302A (en) Method and a monitoring system for monitoring gas stunning of birds
CL2019002787A1 (es) Método y sistema para la evaluación del aliento de un paciente para determinar la concentración de diversos. (divisional solicitud 201800570)
EP4556576A3 (en) Methods to diagnose and treat acute respiratory infections
Liu et al. Almost sure exponential stability of numerical solutions to stochastic delay Hopfield neural networks
WO2016013940A3 (en) Novel test for microbial blood infections
IN2014MU00919A (cg-RX-API-DMAC7.html)
BR112017002876A2 (pt) método de detecção de vírus do computador e sistema deste
BR112015012297A2 (pt) conexões implícitas de gráfico social
GB2519879A (en) Real-time message sentiment awareness
PH12012501043A1 (en) Blood transcriptional signature of active versus latent mycobacterium tuberculosis infection
MX383853B (es) Composiciones y métodos para detectar un contaminante biológico.
BR112018070768A2 (pt) dispositivo de análise de respiração
MX2014000920A (es) Metodo para evaluar la integridad de la pared celular bacteriana.
EP2660717A3 (en) Apparatus for predicate calculation in processor instruction set
CY1120220T1 (el) Μεθοδοι και κυτια για προσδιορισμο της καταστασης λοιμωξης απο φυματιωση
MX376600B (es) Metodo de deteccion de sindrome de dificultad respiratoria aguda y sistemas para la deteccion del sindrome de dificultad respiratoria aguda.
WO2016168344A8 (en) Method and system for microbiome-derived characterization, diagnostics and therapeutics for conditions associated with functional features
WO2013028544A3 (en) Compositions and methods for detecting and discriminating between yeast or mold
GB2568854A (en) Methods for automated controversy detection of content
TW201613017A (en) Method for rejecting tuning disturbances to improve lamp failure prediction quality in thermal processes
MX2019005344A (es) Sistema y metodo para proporcionar informacion sobre el valor de produccion y/o emisiones de un sistema de produccion de hidrocarburo.
Grzebyk et al. Phenotypic evaluation of hydrophobicity and the ability to produce biofilm in coagulase-negative staphylococci isolated from infected very-low-birthweight newborns